THERAPEUTIC RELEVANCE OF PHARMACOKINETICS AND PHARMACODYNAMICS

被引：0
|
作者：
RATAIN, MJ [1 ]
机构：
[1] UNIV CHICAGO,PRITZKER SCH MED,HEMATOL ONCOL SECT,COMM CLIN PHARMACOL,CHICAGO,IL 60637
来源：
SEMINARS IN ONCOLOGY | 1992年 / 19卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：8 / 13
页数：6
相关论文
共 50 条
  • [31] Relevance of CYP2D6 for risperidone pharmacokinetics, pharmacodynamics and adverse reactions
    LLerena, Adrian
    Dorado, Pedro
    Penas-LLedo, Eva M.
    PHARMACOGENOMICS, 2011, 12 (03) : 311 - 311
  • [32] Irinotecan pharmacokinetics-pharmacodynamics: the clinical relevance of prolonged exposure to SN-38
    Mathijssen, RHJ
    Verweij, J
    Loos, WJ
    de Bruijn, P
    Nooter, K
    Sparreboom, A
    BRITISH JOURNAL OF CANCER, 2002, 87 (02) : 144 - 150
  • [33] Pharmacokinetics and pharmacodynamics of insulin glargine 300 U/mL in the treatment of diabetes and their clinical relevance
    Owens, David R.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (08) : 977 - 987
  • [34] Pharmacokinetics-pharmacodynamics of antifungal drugs. Consequences for therapeutic drug monitoring
    Jullien, Vincent
    Lortholary, Olivier
    THERAPIE, 2006, 61 (03): : 209 - 217
  • [35] PLATINUM COMPLEXES IN CANCER MEDICINE - PHARMACOKINETICS AND PHARMACODYNAMICS IN RELATION TO TOXICITY AND THERAPEUTIC ACTIVITY
    CALVERT, H
    JUDSON, I
    VANDERVIJGH, WJF
    CANCER SURVEYS, 1993, 17 : 189 - 217
  • [36] PHARMACOKINETICS AND PHARMACODYNAMICS OF GIVOSIRAN, AN INVESTIGATIONAL RNAI THERAPEUTIC FOR ACUTE INTERMITTENT PORPHYRIA.
    Agarwal, S.
    Habtemarium, B. H.
    Goel, V.
    Attarwala, H.
    Melch, M.
    Jiang, X.
    Simon, A.
    Robbie, G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S34 - S34
  • [37] Therapeutic Drug Monitoring and Individualized Medicine of Dasatinib: Focus on Clinical Pharmacokinetics and Pharmacodynamics
    He, Shiyu
    Bian, Jialu
    Shao, Qianhang
    Zhang, Ying
    Hao, Xu
    Luo, Xingxian
    Feng, Yufei
    Huang, Lin
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [38] LONG-ACTING PROPRANOLOL (INDERAL LA) - PHARMACOKINETICS, PHARMACODYNAMICS AND THERAPEUTIC USE
    MISHRIKI, AA
    WEIDLER, DJ
    PHARMACOTHERAPY, 1983, 3 (06): : 334 - 341
  • [39] Variegin: pharmacokinetics and pharmacodynamics
    Shih, N.
    Amran, F.
    Koh, C. Y.
    Chan, M. Y. Y.
    Kini, R. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 : 5 - 5
  • [40] PACLITAXEL PHARMACOKINETICS AND PHARMACODYNAMICS
    KEARNS, CM
    GIANNI, L
    EGORIN, MJ
    SEMINARS IN ONCOLOGY, 1995, 22 (03) : 16 - 23
12345